Ivana Ozimec

Title: Ivana Ozimec: Innovator in Anti-Inflammatory Compounds

Introduction

Ivana Ozimec is a notable inventor based in Trnovec, Croatia. She has made significant contributions to the field of pharmacology, particularly in the development of anti-inflammatory compounds. With a total of two patents to her name, her work focuses on innovative solutions for inhibiting tumor necrosis factor production.

Latest Patents

Ozimec's latest patents include "2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof." This invention relates to compounds of the 2-thia-dibenzoazulene class, their pharmacologically acceptable salts and solvates, and processes for their preparation. The compounds exhibit anti-inflammatory effects, particularly in inhibiting tumor necrosis factor-alpha (TNF-α) and interleukin-1 (IL-1) production, along with their analgesic action. Another patent, "1- or 3-thia-benzonaphthoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof," focuses on benzonaphthoazulene derivatives of the thiophene class, highlighting similar pharmacological benefits.

Career Highlights

Throughout her career, Ivana Ozimec has worked with prominent organizations, including GlaxoSmithKline Istraživački Centar Zagreb D.o.o. and GlaxoSmithKline Istraživački Centar Zagreb, D.o.o. Her experience in these companies has allowed her to contribute to significant advancements in pharmaceutical research and development.

Collaborations

Ozimec has collaborated with notable colleagues such as Mladen Mercep and Milan Mesic. These partnerships have further enriched her research and innovation efforts in the field of anti-inflammatory compounds.

Conclusion

Ivana Ozimec stands out as a pioneering inventor in the realm of pharmacology, with her patents reflecting her commitment to developing effective anti-inflammatory solutions. Her work continues to impact the medical field positively.